Education
About Us
Working with TipRanks
Follow Us
Petmed Express (PETS)
NASDAQ:PETS
PETS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.90 - $6.85
Previous CloseN/A
Volume75.70K
Average Volume (3M)217.06K
Market Cap
$86.55M
Enterprise Value$50.47M
Total Cash (Recent Filing)$53.14M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)378.5
Beta0.93
Next Earnings
May 12, 2025EPS Estimate
-0.05Last Dividend Ex-Date
Aug 11, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding20,656,458
10 Day Avg. Volume201,333
30 Day Avg. Volume217,065
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.36
Price to Cash Flow (P/CF)-18.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.58
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.64
Enterprise Value/Ebitda6.41
Forecast
1Y Price Target
$4.00Price Target Upside0.00%
Rating ConsensusHold
Number of Analyst Covering1
---
Petmed Express News
PremiumCompany Announcements
PetMed Express Earnings Call Highlights Profitability Amid Sales Challenges
PremiumCompany Announcements
PetMed Express Shows EBITDA Growth Amid Transformation
PremiumCompany Announcements
PetMed Express Implements Shareholder Rights Protection Plan---
Bulls Say, Bears Say
Bulls Say
Financial StabilityThe company is well-capitalized to make it through the turnaround, with $50M of cash and no debt.
Profit MarginsGross margins for the quarter reached 29.1%, ahead of the 27.4% estimate, due to limited promotions and a focus on profitability.
Bears Say
Customer BaseThe company is likely losing customers to competitors with the absence of promotions.
Financial OutlookThe company will continue to be under pressure in the near term with financials remaining soft given the lack of visibility into the timeline of the turnaround and the continued macro challenges.
Revenue PerformanceQ2 revenue declined 16% to $59.6M, which was below the $66.0M estimate, indicating customers reduced spending or sought promotions from competitors.
---
Ownership Overview
18.24% Insiders
14.37% Mutual Funds
16.18% Other Institutional Investors
44.01% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by Petmed Express
Desktop Users
Mobile Users
PETS FAQ
What was Petmed Express’s price range in the past 12 months?
Petmed Express lowest stock price was $2.90 and its highest was $6.85 in the past 12 months.
What is Petmed Express’s market cap?
Petmed Express’s market cap is $86.55M.
When is Petmed Express’s upcoming earnings report date?
Petmed Express’s upcoming earnings report date is May 12, 2025 which is in 39 days.
How were Petmed Express’s earnings last quarter?
Petmed Express released its earnings results on Feb 10, 2025. The company reported -$0.03 earnings per share for the quarter, missing the consensus estimate of $0.005 by -$0.035.
Is Petmed Express overvalued?
According to Wall Street analysts Petmed Express’s price is currently same.
Does Petmed Express pay dividends?
Petmed Express pays a Quarterly dividend of $0.3 which represents an annual dividend yield of N/A. See more information on Petmed Express dividends here
What is Petmed Express’s EPS estimate?
Petmed Express’s EPS estimate is -0.05.
How many shares outstanding does Petmed Express have?
Petmed Express has 20,656,458 shares outstanding.
What happened to Petmed Express’s price movement after its last earnings report?
Petmed Express reported an EPS of -$0.03 in its last earnings report, missing expectations of $0.005. Following the earnings report the stock price went down -14.042%.
Which hedge fund is a major shareholder of Petmed Express?
Currently, no hedge funds are holding shares in PETS
---
Petmed Express Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$4.00 (0.00% )
$4.00 (0.00% )
Blogger Sentiment
Bullish
PETS Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 130.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.46%
12-Months-Change
Fundamentals
Return on Equity
0.36%
Trailing 12-Months
Asset Growth
-16.47%
Trailing 12-Months
Company Description
Petmed Express
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
---
PETS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant progress in profitability and cost-cutting measures, alongside challenges in sales and competitive pressures. The company is making strategic investments to modernize its technology and improve customer experience, aiming for long-term growth.Read More>---
PETS Stock 12 Month Forecast
Average Price Target
$4.00
▲(0.00% Upside)
Technical Analysis
Best Analysts Covering PETS
1 Year
1 Year Success Rate
12/18 ratings generated profit
1 Year Average Return
+8.24%
reiterated a sell rating 5 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +8.24% per trade.
---